Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma total assets
Total assets on the balance sheet at the end of each period.
Matinas BioPharma's total assets was $3.41M at Jun 30, 2026. For fiscal 2025 it was $7.21M, down 43.0% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $70.97M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.21M | -43.0% |
| FY2024 | Dec 31, 2024 | $12.64M | -49.6% |
| FY2023 | Dec 31, 2023 | $25.10M | -44.0% |
| FY2022 | Dec 31, 2022 | $44.82M | -26.9% |
| FY2021 | Dec 31, 2021 | $61.33M | -13.6% |
| FY2020 | Dec 31, 2020 | $70.97M | +76.4% |
| FY2019 | Dec 31, 2019 | $40.24M | +101.8% |
| FY2018 | Dec 31, 2018 | $19.94M | +38.3% |
| FY2017 | Dec 31, 2017 | $14.42M | +46.9% |
| FY2016 | Dec 31, 2016 | $9.82M | +16.8% |
| FY2015 | Dec 31, 2015 | $8.41M | +150.1% |
| FY2014 | Dec 31, 2014 | $3.36M | -70.3% |
| FY2013 | Dec 31, 2013 | $11.33M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.41M | -70.1% |
| Q1 FY2026 | Mar 31, 2026 | $5.87M | -51.2% |
| Q4 FY2025 | Dec 31, 2025 | $7.21M | -43.0% |
| Q3 FY2025 | Sep 30, 2025 | $9.70M | -52.9% |
| Q2 FY2025 | Jun 30, 2025 | $11.42M | -53.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.04M | -38.6% |
| Q4 FY2024 | Dec 31, 2024 | $12.64M | -49.6% |
| Q3 FY2024 | Sep 30, 2024 | $20.58M | -30.9% |
| Q2 FY2024 | Jun 30, 2024 | $24.37M | -28.4% |
| Q1 FY2024 | Mar 31, 2024 | $19.61M | -48.7% |
| Q4 FY2023 | Dec 31, 2023 | $25.10M | -44.0% |
| Q3 FY2023 | Sep 30, 2023 | $29.79M | -37.3% |
| Q2 FY2023 | Jun 30, 2023 | $34.03M | -35.1% |
| Q1 FY2023 | Mar 31, 2023 | $38.26M | -31.4% |
| Q4 FY2022 | Dec 31, 2022 | $44.82M | -26.9% |
| Q3 FY2022 | Sep 30, 2022 | $47.55M | -29.0% |
| Q2 FY2022 | Jun 30, 2022 | $52.42M | -25.1% |
| Q1 FY2022 | Mar 31, 2022 | $55.78M | -22.9% |
| Q4 FY2021 | Dec 31, 2021 | $61.33M | -13.6% |
| Q3 FY2021 | Sep 30, 2021 | $66.98M | -10.5% |
| Q2 FY2021 | Jun 30, 2021 | $69.97M | -11.5% |
| Q1 FY2021 | Mar 31, 2021 | $72.35M | -14.0% |
| Q4 FY2020 | Dec 31, 2020 | $70.97M | +76.4% |
| Q3 FY2020 | Sep 30, 2020 | $74.81M | +66.9% |
| Q2 FY2020 | Jun 30, 2020 | $79.09M | +64.0% |
| Q1 FY2020 | Mar 31, 2020 | $84.11M | +66.3% |
| Q4 FY2019 | Dec 31, 2019 | $40.24M | +101.8% |
| Q3 FY2019 | Sep 30, 2019 | $44.82M | +211.0% |
| Q2 FY2019 | Jun 30, 2019 | $48.21M | +200.5% |
| Q1 FY2019 | Mar 31, 2019 | $50.57M | +340.2% |
| Q4 FY2018 | Dec 31, 2018 | $19.94M | +38.3% |
| Q3 FY2018 | Sep 30, 2018 | $14.41M | -12.8% |
| Q2 FY2018 | Jun 30, 2018 | $16.04M | -9.9% |
| Q1 FY2018 | Mar 31, 2018 | $11.49M | -47.9% |
| Q4 FY2017 | Dec 31, 2017 | $14.42M | +46.9% |
| Q3 FY2017 | Sep 30, 2017 | $16.52M | +46.1% |
| Q2 FY2017 | Jun 30, 2017 | $17.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.03M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.82M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.31M | – |
See a number that looks wrong?